Strikingly, MTHFD2 raises the basal and IFN-γ-stimulated PD-L1 expression in both basal and IFN-γ-stimulating conditions, which could be the epitome of the linking of onco-metabolic genes and tumor immunoresistance [45]. The gene discussed is CD274; the disease is neoplasm.